To further document the correlation between miR-26a and KRT19, we divided the CCA patients into two subgroups (KRT19high and KRT19low) by using the medium of KRT19 expression in tumor tissues as cutoff. This evidence concerns the gene KRT19 and cholangiocarcinoma.